SREBP-1c is implicated in the generation of diacylglycerol (DAG) and ceramides, molecules that induce inflammation by interacting with tumor necrosis factor-α (TNF-α), thereby exacerbating insulin resistance [49]. Here, TNF is linked to Insulin resistance.